T. Rowe Price Investment Management, Inc. filed Amendment No. 3 to its Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 14,347,736 shares of Shattuck Labs Inc common stock as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: T. Rowe Price Investment Management, Inc. reported beneficial ownership of 14,347,736 shares of Shattuck Labs Inc common stock.
- Percent of class: The reported holdings represent 14.3% of the outstanding class of common stock.
- Sole voting power: The filing reports sole voting power over 14,319,457 shares, with no shared voting power.
- Sole dispositive power: The filing reports sole dispositive power over 14,347,736 shares, with no shared dispositive power.
- T. Rowe Price Small-Cap Stock Fund interest: T. Rowe Price Small-Cap Stock Fund, for which T. Rowe Price Investment Management, Inc. serves as investment adviser, holds an interest in 3,487,102 of the reported shares, representing 5.5% of the class.
- Event date: The date of the event requiring this filing is September 30, 2026.
T. Rowe Price Investment Management Discloses Amended Ownership Position in Shattuck Labs
According to the filing, T. Rowe Price Investment Management, Inc., a Maryland-incorporated investment adviser, submitted Amendment No. 3 to Schedule 13G reporting its beneficial ownership in Shattuck Labs Inc (NASDAQ:STTK), whose principal executive offices are located at 500 W. 5th Street, Austin, TX 78701. The filing was signed by Ellen York, Vice President, on November 16, 2026, and reflects ownership as of the event date of September 30, 2026.
The filing discloses that T. Rowe Price Investment Management holds an aggregate of 14,347,736 shares, equal to 14.3% of the class. Of those shares, 14,319,457 are held with sole voting power and 14,347,736 with sole dispositive power. No shares are reported with shared voting or shared dispositive power. The filing identifies T. Rowe Price Small-Cap Stock Fund as holding an interest in 3,487,102 of those shares, representing 5.5% of the class, with that fund retaining the right to receive dividends and sale proceeds attributable to its portion.
The filing states that T. Rowe Price Investment Management "does not serve as custodian of the assets of any of its clients" and that "the ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser." The filing also includes a certification that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
What Was Disclosed
T. Rowe Price Investment Management, Inc. filed Amendment No. 3 to Schedule 13G reporting 14,347,736 shares, or 14.3%, of Shattuck Labs Inc common stock as of September 30, 2026, with T. Rowe Price Small-Cap Stock Fund identified as holding 3,487,102 shares representing 5.5% of the class.



Please wait processing your request...